Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
Cell · 2025-05 · 188 (9) · 2372-2389.e35
DOI: 10.1016/j.cell.2025.03.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-05. Verfasst von Taisuke Kondo und 24 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Receptors, Antigen, T-Cell, Immunotherapy, Adoptive, T-Lymphocytes. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Natural Sciences and Engineering Research Council of Canada, Fonds Québécois de la Recherche sur la Nature et les Technologies.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Department of Physics, McGill University, Montréal, QC, Canada; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
- Immunodynamics Group, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheuma…
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; CAMS Oxford Institute, University of Oxford, Oxford, UK.
- Immunodynamics Group, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Molecular Cell Biology, Institute for Cancer Research, O…
Förderung
- Intramural NIH HHS
- Natural Sciences and Engineering Research Council of Canada
- Fonds Québécois de la Recherche sur la Nature et les Technologies
- Canadian Institutes of Health Research
- National Cancer Institute
- National Institutes of Health
- National Science Foundation
- Chinese American Medical Society
Zitieren
APA
Kondo, T., Bourassa, F. X. P., Achar, S., DuSold, J., Céspedes, P. F., Ando, M., Dwivedi, A., Moraly, J., Chien, C., Majdoul, S., Kenet, A. L., Wahlsten, M., Kvalvaag, A., Jenkins, E., Kim, S. P., Ade, C. M., Yu, Z., Gaud, G., Davila, M., …, & Taylor, N. (2025). Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity. Cell, 188(9), 2372-2389.e35. https://doi.org/10.1016/j.cell.2025.03.017
Vancouver
Kondo T, Bourassa FXP, Achar S, DuSold J, Céspedes PF, Ando M, et al. Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity. Cell. 2025;188(9):2372-2389.e35. doi:10.1016/j.cell.2025.03.017
BibTeX
@article{Kondo2025,
author = {Kondo, Taisuke and Bourassa, François X P and Achar, Sooraj and DuSold, Justyn and Céspedes, Pablo F and Ando, Makoto and Dwivedi, Alka and Moraly, Josquin and Chien, Christopher and Majdoul, Saliha and Kenet, Adam L and Wahlsten, Madison and Kvalvaag, Audun and Jenkins, Edward and Kim, Sanghyun P and Ade, Catherine M and Yu, Zhiya and Gaud, Guillaume and Davila, Marco and Love, Paul and Yang, James C and Dustin, Michael L and Altan-Bonnet, Grégoire and François, Paul and Taylor, Naomi},
title = {Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity},
journal = {Cell},
year = {2025},
volume = {188},
number = {9},
pages = {2372--2389.e35},
doi = {10.1016/j.cell.2025.03.017}
}
EUVIMED